Sign in

CIK 0001641281 · <br>Emerging growth company

Bolt Biotherapeutics, Inc.

Sign in to watch
Ticker
BOLT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
472804636
Phone
650-665-9295
Business address
900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
Former names
Bolt Therapeutics, Inc.
Open-market buys, last 90 days
$319,000
in 1 filing
Open-market sales, last 90 days
$128,281
in 3 filings

Net +$190,719. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Coastlands Capital LP +$319K 10% owner 1 filing
  2. Quinn William P. −$58K President, CEO and CFO sold 41% of stake
  3. Yonehiro Grant −$44K Chief Operating Officer sold 43% of stake
  4. Nemec Sarah −$26K Senior VP, Finance and PAO sold 31% of stake
Date Insider Transaction Shares Price Value Owned after
2021-02-09 Vivo Capital VIII, LLC 10% owner Conversion · Series B Preferred Stock −472,296 0
2021-02-09 Vivo Capital VIII, LLC 10% owner Option exercise · Warrant (Right to Buy) −17,711 0
2021-02-09 Vivo Capital VIII, LLC 10% owner Conversion · Series B Preferred Stock −1,092,080 0
2021-02-09 Vivo Capital VIII, LLC 10% owner Conversion · Series C-1 Preferred Stock −317,922 0
2021-02-09 Vivo Capital VIII, LLC 10% owner Conversion · Series C-2 Preferred Stock −345,568 0
2021-02-09 Vivo Capital VIII, LLC 10% owner Option exercise · Warrant (Right to Buy) −40,953 0
2021-02-09 Vivo Capital VIII, LLC 10% owner Conversion · Series B Preferred Stock −150,802 0
2021-02-09 Vivo Capital VIII, LLC 10% owner Conversion · Series C-1 Preferred Stock −43,901 0
2021-02-09 Vivo Capital VIII, LLC 10% owner Conversion · Series C-2 Preferred Stock −47,718 0
2021-02-09 Vivo Capital VIII, LLC 10% owner Option exercise · Warrant (Right to Buy) −5,655 0
2021-02-09 LAPORTE KATHLEEN Director Purchase +1,200 $20.00 $24K 1,200
2021-02-09 SHAH MAHENDRA Director Conversion +944,056 958,341
2021-02-09 SHAH MAHENDRA Director Conversion +472,296 1,430,637
2021-02-09 SHAH MAHENDRA Director Option exercise +17,711 $0.07 $1K 1,448,348
2021-02-09 SHAH MAHENDRA Director Sale −62 $20.00 $1K 1,448,286
2021-02-09 SHAH MAHENDRA Director Conversion · Series A- 1 Preferred Stock −944,056 0
2021-02-09 SHAH MAHENDRA Director Conversion · Series B Preferred Stock −472,296 0
2021-02-09 SHAH MAHENDRA Director Option exercise · Warrant (Right to Buy) −17,711 0
2021-02-09 HEALY JAMES Director Conversion +1,104,209 1,104,209
2021-02-09 HEALY JAMES Director Conversion +1,200,228 2,304,437

Page 15 of 17 · 337 trades